Monthly Archives: April 2012

Seven Surprising Facts About Biogen-Idec’s Developmental ‘Blockbuster’ for Multiple Sclerosis

The recent news from Biogen-Idec of the success of their experimental drug BG-12 for relapsing-remitting multiple sclerosis is in many ways remarkable. Although BG-12 is not approved yet, here are seven things about it which challenge many of the widely held beliefs about how we should best discover drugs today.

Posted in Uncategorised